UiPath Inc.

NYSE:PATH Rapporto sulle azioni

Cap. di mercato: US$7.8b

UiPath Crescita futura

Future criteri di controllo 1/6

UiPath prevede che gli utili e i ricavi cresceranno rispettivamente di 19.3% e 9.7% all'anno. Si prevede che l'EPS crescerà di 25.9% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 0.8% in 3 anni.

Informazioni chiave

19.3%

Tasso di crescita degli utili

25.9%

Tasso di crescita dell'EPS

Software crescita degli utili17.3%
Tasso di crescita dei ricavi9.7%
Rendimento futuro del capitale proprio0.8%
Copertura analitica

Good

Ultimo aggiornamento22 Nov 2024

Aggiornamenti recenti sulla crescita futura

Earnings Update: UiPath Inc. (NYSE:PATH) Just Reported And Analysts Are Trimming Their Forecasts

Jun 01
Earnings Update: UiPath Inc. (NYSE:PATH) Just Reported And Analysts Are Trimming Their Forecasts

Recent updates

UiPath: Will Become A Different Company

Nov 17

UiPath: Buy For Strong Recovery Potential, Future Enterprise AI Growth

Oct 28

UiPath: Great Opportunity To Buy This AI Stock At A Cheap Price

Oct 14

UiPath Inc.'s (NYSE:PATH) Share Price Could Signal Some Risk

Oct 04
UiPath Inc.'s (NYSE:PATH) Share Price Could Signal Some Risk

UiPath Inc.: Bullish Support Is Finally Here - Turnaround Likely Prolonged

Sep 14

UiPath Q2 Earnings: On The Path Higher (Rating Upgrade)

Sep 06

Why UiPath Inc. (NYSE:PATH) Could Be Worth Watching

Aug 23
Why UiPath Inc. (NYSE:PATH) Could Be Worth Watching

UiPath: Fighting Headwinds With Strong Fundamentals And AI Optionality

Aug 13

UiPath: Not Your Path To Profits

Aug 05

Calculating The Fair Value Of UiPath Inc. (NYSE:PATH)

Aug 02
Calculating The Fair Value Of UiPath Inc. (NYSE:PATH)

UiPath: On The Long Road To Recovery

Jul 13

UiPath Crashes On Generative AI Headwinds: Buy The Fear (Ratings Upgrade)

Jun 30

Earnings Update: UiPath Inc. (NYSE:PATH) Just Reported And Analysts Are Trimming Their Forecasts

Jun 01
Earnings Update: UiPath Inc. (NYSE:PATH) Just Reported And Analysts Are Trimming Their Forecasts

The Price Is Right For UiPath Inc. (NYSE:PATH) Even After Diving 37%

May 31
The Price Is Right For UiPath Inc. (NYSE:PATH) Even After Diving 37%

UiPath Earnings: It Would Be A Sin To Compound My Mistake (Rating Downgrade)

May 30

UiPath Q1 Earnings Preview: Enterprise Demand Should Sustain

May 24

UiPath: A Hold Based On Demystifying The AI Hype (Rating Downgrade)

Apr 24

UiPath: Still Unloved

Apr 18

UiPath: Post-Earnings Selloff Is A Gift, Positive GAAP Income, Net Cash (Upgrade)

Mar 20

Why Investors Shouldn't Be Surprised By UiPath Inc.'s (NYSE:PATH) P/S

Feb 28
Why Investors Shouldn't Be Surprised By UiPath Inc.'s (NYSE:PATH) P/S

UiPath: I Am Not Ready To Pay Premium Here

Feb 19

Is UiPath Inc. (NYSE:PATH) Potentially Undervalued?

Feb 01
Is UiPath Inc. (NYSE:PATH) Potentially Undervalued?

UiPath: Leader In An Unloved Segment

Jan 16

UiPath's Bots Make Generative AI Apps Work Better

Jan 09

UiPath: From IPO Hype To Market Leadership, And Challenges Ahead

Dec 29

A Look At The Fair Value Of UiPath Inc. (NYSE:PATH)

Nov 27
A Look At The Fair Value Of UiPath Inc. (NYSE:PATH)

UiPath: Correction Over; Outperformance Ahead

Nov 26

UiPath May Beat Expectations Again, Staying Expensive

Nov 20

UiPath: Left Underappreciated

Oct 16

UiPath: The Real AI Pioneer

Sep 14

UiPath Q2 2024 Earnings Preview: I Expect FY24 Guidance To Be Raised

Sep 05

Previsioni di crescita degli utili e dei ricavi

NYSE:PATH - Stime future degli analisti e dati finanziari passati (USD Millions )
DataRicaviGuadagniFlusso di cassa liberoLiquidità dell'operazioneAvg. Numero di analisti
1/31/20271,757-1263843798
1/31/20261,580-14235435722
1/31/20251,423-17232533022
7/31/20241,383-112327334N/A
4/30/20241,354-87325332N/A
1/31/20241,308-90292299N/A
10/31/20231,211-151242247N/A
7/31/20231,148-178168178N/A
4/30/20231,103-23894110N/A
1/31/20231,059-328-34-10N/A
10/31/20221,040-364-135-110N/A
7/31/2022998-429-132-108N/A
4/30/2022951-408-109-90N/A
1/31/2022892-526-67-55N/A
10/31/2021810-436-42-31N/A
7/31/2021737-384-52N/A
4/30/2021681-2843036N/A
1/31/2021608-922629N/A
1/31/2020336-520-380-359N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: Si prevede che PATH rimarrà non redditizia nei prossimi 3 anni.

Guadagni vs Mercato: Si prevede che PATH rimarrà non redditizia nei prossimi 3 anni.

Guadagni ad alta crescita: Si prevede che PATH rimarrà non redditizia nei prossimi 3 anni.

Ricavi vs Mercato: Si prevede che il fatturato di PATH ( 9.7% all'anno) crescerà più rapidamente del mercato US ( 8.9% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di PATH ( 9.7% all'anno) crescerà più lentamente di 20% all'anno.


Previsioni di crescita dell'utile per azione


Rendimento futuro del capitale proprio

ROE futuro: Si prevede che il Return on Equity di PATH sarà basso tra 3 anni ( 0.8 %).


Scoprire le aziende in crescita